Additional information
| Active substance | Clozapine |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Rare, but potential risk present |
| Lab Test | Regular monitoring of blood counts due to risk of agranulocytosis |
| Strength | 25mg |
| Also known as | Clozaril |
| Blood pressure | Can cause orthostatic hypotension |
| Trade name | Clozaril, Leponex, others |
| Storage conditions | Store at room temperature, 20В°C to 25В°C (68В°F to 77В°F) |
| Chemical name | 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine |
| Formula | C18H19ClN4 |
| Substance class | Atypical antipsychotic |
| Main action | Acts as an antagonist on various neurotransmitter receptors in the brain, including serotonin and dopamine receptors |
| Half-life | Approximately 12 hours |
| Dosage (medical) | Typically 300-450 mg/day, split into two or three doses |
| Dosage (sports) | Not applicable |
| Effects | Reduction in psychotic symptoms and mood stabilization |
| Side effects | Agranulocytosis, seizures, myocarditis, orthostatic hypotension, anticholinergic side effects, weight gain |
| Use in sports | None |
| Manufacturer | Sun Pharma Laboratories Ltd. |
| Packing | 10 tabs/blister |

EPO 3000iu GENERIC
Seretide Disckus (Advair) 500 mcg Glaxosmithkline
Clenbuterolhydrochlorid Sopharma
FUCIDIN 500 mg Abdi Ibragim
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS
Zyban Glaxosmithkline
Januvia 100mg Merckgroup 

Reviews
There are no reviews yet.